Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Klinische Padiatrie|November 27, 2004
Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study groupS Stegmaier, I Leuschner, E Aakcha-Rudel, et al.
Klinische Padiatrie|May 1, 1986
[Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology]J Treuner, P Kaatsch, Y Anger, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2aR Handgretinger, P Baader, R Dopfer, et al.
Pediatric Blood & Cancer|December 8, 2005
Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS)M Paulides, A Kremers, W Stöhr, et al.
Medical and Pediatric Oncology|December 7, 2000
Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim resultsF H Schilling, F Berthold, R Erttmann, et al.
Klinische Padiatrie|July 1, 1990
[The role of interferons in neuroblastoma. 2: Immunomodulatory effects]R Handgretinger, G Bruchelt, B Daurer, et al.
Pediatric Blood & Cancer|April 22, 2006
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance SystemW Stöhr, M Paulides, S Bielack, et al.
Immunology Letters|September 1, 1989
Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donorsG Bruchelt, R Handgretinger, G Fierlbeck, et al.
Journal of Bioluminescence and Chemiluminescence|April 1, 1989
Effects of granulocytes on human neuroblastoma cells measured by chemiluminescence and chromium-51 release assayG Bruchelt, R Handgretinger, A Kimmig, et al.
Klinische Padiatrie|July 1, 1990
[The role of interferons in neuroblastoma. 1: Antiproliferative effects]G Bruchelt, R Handgretinger, K Schilbach-Stückle, et al.
Pageof 12